Cargando…

The utility of B-type natriuretic peptide in differentiating decompensated heart failure from lung disease in patients presenting to the emergency department with dyspnea

Detalles Bibliográficos
Autores principales:	Villacorta, H, Campos, A, Duarte, N, Mesquita, ET
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301016/ http://dx.doi.org/10.1186/cc2214

Ejemplares similares

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2003)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population
por: Chen, Li Juen, et al.
Publicado: (2016)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Accuracy of B-natriuretic peptide for the diagnosis of decompensated heart failure in muscular dystrophies patients with chronic respiratory failure
por: Meng, Paris, et al.
Publicado: (2018)

Clinical presentation of patients with chest pain and acute aortic dissection admitted in the chest pain unit
por: Clare, CM, et al.
Publicado: (2003)

Effects of exertional dyspnea on early mobilization of patients with acute decompensated heart failure
por: Yamazaki, Yota, et al.
Publicado: (2022)

The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic review
por: Korenstein, Deborah, et al.
Publicado: (2007)

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
por: Kadri, Amer N., et al.
Publicado: (2018)

In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure
por: Di Somma, Salvatore, et al.
Publicado: (2011)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

The Yin and Yang of dyspnea in the emergency department: heart failure or COPD?
por: Canpolat, Uğur, et al.
Publicado: (2013)

Acute cardiogenic dyspnea in the emergency department: accuracy of lung ultrasound
por: Spinelli, A, et al.
Publicado: (2014)

Role of chronobiological rhythms in acute aortic dissection
por: Clare, CM, et al.
Publicado: (2003)

Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3
por: Stoica, Alexandra, et al.
Publicado: (2018)

Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
por: Waldum, Bård, et al.
Publicado: (2013)

Plasma endothelin-1 and natriuretic peptide levels and antioxidant capacity of heart transplanted patients
por: Olejarova, I, et al.
Publicado: (2000)

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
por: Maisel, Alan S., et al.
Publicado: (2011)

Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report
por: Tiepolo, Ambre, et al.
Publicado: (2019)

Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
por: Pan, Hai-Yan, et al.
Publicado: (2014)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure
por: Yoon, Jae Yong, et al.
Publicado: (2019)

B-type natriuretic peptide/ferritin ratio as a predictor of the risk of developing acute renal injury in acute decompensated heart failure
por: Ceyhun, Gökhan, et al.
Publicado: (2021)

B-type natriuretic peptide testing reduces time to discharge in patients presenting with acute dyspnea (the BASEL study)
por: Mueller, C, et al.
Publicado: (2004)

Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry
por: Perrone, SV, et al.
Publicado: (2003)

Brain natriuretic peptide in acute brain diseases
por: Špatenková, V, et al.
Publicado: (2003)

Determinants of natriuretic peptides in early septic shock
por: Witthaut, R, et al.
Publicado: (1998)

Natriuretic peptides and cGMP in metabolic disease
por: Collins, Sheila
Publicado: (2015)

Chest ultrasounds and X-rays compared in patients with acute dyspnea in an Emergency Department
por: Martino, IF, et al.
Publicado: (2014)

Should left ventricular failure be part of the risk score in acute ischemic syndrome without ST elevation?
por: Araujo, M, et al.
Publicado: (2003)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

The use of specific para-clinical examinations in patients presenting with dyspnea
por: Nielsen, Marie Krogh, et al.
Publicado: (2015)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Prognostic risk markers at 180 days in patients with ischemic heart syndrome without ST elevation
por: Araujo, M, et al.
Publicado: (2003)

Bedside Ultrasonography versus Brain Natriuretic Peptide in Detecting Cardiogenic Causes of Acute Dyspnea
por: Golshani, Keihan, et al.
Publicado: (2016)

Snake venom natriuretic peptides: Potential molecular probes
por: Sridharan, Sindhuja, et al.
Publicado: (2015)

Diagnostic accuracy of plasma brain natriuretic peptide for evaluation of dyspnea NYHA-III and NYHA-IV in emergency department of tertiary care hospital
por: Saghir, Hina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5l1hdis8hkfqusd5gmfrcdfj8i